GlassScriptPhysician profile
Bethany Ann Cluskey
NPI 1841580644
$2,805.58
in general payments reported to CMS, 2019-2025
28 companies · $666 in 2025
The $666 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $254 · 2021: $555 · 2022: $417 · 2023: $239 · 2024: $389 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $826.32 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Coopersurgical, INC. | $232.34 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $230.25 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $216.12 | 2019-2025 | Aptima, Myosure Tissue Removal Device, Acessa Provu System |
| Exeltis, USA INC. | $141.80 | 2020-2025 | Slynd |
| Pfizer INC. | $128.59 | 2024-2025 | |
| Biogen, INC. | $117.85 | 2025 | Zurzuvae |
| Avion Pharmaceuticals | $112.04 | 2020-2022 | |
| Organon LLC | $105.15 | 2021-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $99.36 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $98.11 | 2019-2021 | |
| Therapeuticsmd, INC. | $81.25 | 2019-2022 | |
| Seqirus USA INC | $71.06 | 2024-2025 | Flucelvax, Fluad |
| Mayne Pharma Commercial LLC | $38.02 | 2022 | |
| Aspira Women'S Health INC | $35.40 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $34.64 | 2025 | Intrarosa, Femring |
| Amgen INC. | $32.81 | 2019 | |
| Daiichi Sankyo INC. | $27.41 | 2022 | |
| Myovant Sciences INC. | $23.78 | 2021 | |
| Exact Sciences Corporation | $22.71 | 2025 | The Cologuard Plus Collection Kit |
| Gynesonics, INC. | $20.95 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Duchesnay USA Incorporated | $17.79 | 2019 | |
| Novo Nordisk INC | $17.26 | 2022 | |
| Allergan, INC. | $16.36 | 2020 | |
| Lupin INC. | $15.56 | 2019 | |
| Channel Medsystems, INC. | $14.65 | 2023 | |
| Monaghan Medical Corporation | $14.45 | 2023 | Aeroeclipse |
| Vertical Pharmaceuticals, LLC | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Cluskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.